Patents by Inventor Artem G. Evdokimov

Artem G. Evdokimov has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Proteins toxic to hemipteran insect species
    Patent number: 9713334
    Abstract: The present invention discloses Hemipteran insect inhibitory proteins, methods of using such proteins, nucleotide sequences encoding such proteins, methods of detecting and isolating such proteins, and their use in agricultural systems.
    Type: Grant
    Filed: February 4, 2016
    Date of Patent: July 25, 2017
    Assignee: Monsanto Technology LLC
    Inventors: James A. Baum, Artem G. Evdokimov, Farhad Moshiri, Timothy J. Rydel, Eric J. Sturman, Moritz von Rechenberg, Halong Vu, Andrew M. Wollacott, Meiying Zheng
  • Compositions and methods for custom site-specific DNA recombinases
    Patent number: 9708589
    Abstract: The invention relates to biotechnology and provides novel compositions and methods for sequence-specific or sequence-directed transcription activator-like effector recombinases. The invention also provides novel plant transformation vectors and expression cassettes, which include novel combinations of chimeric recombinases with plant expression and transformation elements. Methods for gene-targeting, DNA sequence removal, and molecular breeding are also provided.
    Type: Grant
    Filed: December 17, 2013
    Date of Patent: July 18, 2017
    Assignee: Monsanto Technology LLC
    Inventors: Jonathan C. Lamb, Artem G. Evdokimov
  • PROLYL HYDROXYLASE INHIBITORS AND METHODS OF USE
    Publication number: 20170189387
    Abstract: The present disclosure relates to HIF-1? prolyl hydroxylase inhibitors, compositions which comprise the HIF-1? prolyl hydroxylase inhibitors described herein and to methods for controlling, inter alia, Peripheral Vascular Disease (PVD), Coronary Artery Disease (CAD), heart failure, ischemia, and anemia.
    Type: Application
    Filed: January 31, 2017
    Publication date: July 6, 2017
    Inventors: Richard Masaru Kawamoto, Shengde Wu, Artem G. Evdokimov, Kenneth D. Greis, Angelique Sun Boyer, Namal C. Warshakoon
  • Prolyl hydroxylase inhibitors and methods of use
    Patent number: 9598370
    Abstract: The present disclosure relates to HIF-1? prolyl hydroxylase inhibitors, compositions which comprise the HIF-1? prolyl hydroxylase inhibitors described herein and to methods for controlling, inter alia, Peripheral Vascular Disease (PVD), Coronary Artery Disease (CAD), heart failure, ischemia, and anemia.
    Type: Grant
    Filed: September 15, 2015
    Date of Patent: March 21, 2017
    Assignee: Akebia Therapeutics, Inc.
    Inventors: Richard Masaru Kawamoto, Shengde Wu, Artem G. Evdokimov, Kenneth D. Greis, Angelique Sun Boyer, Namal C. Warshakoon
  • METHODS AND COMPOSITIONS FOR HERBICIDE TOLERANCE IN PLANTS
    Publication number: 20170058290
    Abstract: The invention relates to biotechnology and provides novel recombinant DNA molecules and engineered proteins for conferring tolerance to protoporphyrinogen oxidase-inhibitor herbicides. The invention also provides herbicide tolerant transgenic plants, seeds, cells, and plant parts containing the recombinant DNA molecules, as well as methods of using the same.
    Type: Application
    Filed: August 4, 2016
    Publication date: March 2, 2017
    Inventors: Artem G. Evdokimov, Clayton T. Larue, Farhad Moshiri, Joel E. Ream, Xuefeng Zhou
  • METHODS AND COMPOSITIONS FOR HERBICIDE TOLERANCE IN PLANTS
    Publication number: 20170037427
    Abstract: The invention relates to biotechnology and provides novel recombinant DNA molecules and engineered proteins for conferring tolerance to protoporphyrinogen oxidase-inhibitor herbicides. The invention also provides herbicide tolerant transgenic plants, seeds, cells, and plant parts containing the recombinant DNA molecules, as well as methods of using the same.
    Type: Application
    Filed: July 29, 2016
    Publication date: February 9, 2017
    Inventors: Artem G. Evdokimov, Clayton T. Larue, Farhad Moshiri, Joel E. Ream, Xuefeng Zhou
  • MULTI FUNCTIONAL TOXINS
    Publication number: 20170029844
    Abstract: Pesticidal proteins are provided that combine two or more modes of action into a single molecule. These pesticidal proteins therefor exhibit greater efficacy and/or durability of resistance, for the purposes of pest control, and can be utilized for pest control by provision in the diet of a pest organism, or by topical application to crop plants and/or pests. Methods and compositions for producing and using such proteins are also provided.
    Type: Application
    Filed: July 22, 2016
    Publication date: February 2, 2017
    Inventors: Timothy K. Ball, Artem G. Evdokimov, Larry A. Gilbertson, Victor M. Guzov, Jeffrey A. Haas, Qing Huai, Sergey Ivashuta, Melissa M. Kemp, Yifei Kong, Thomas M. Malvar, Byron V. Olsen, Parthasarathy Ramaseshadri, Brian E. Weiner
  • Proteins Toxic To Hemipteran Insect Species
    Publication number: 20160150795
    Abstract: The present invention discloses Hemipteran insect inhibitory proteins, methods of using such proteins, nucleotide sequences encoding such proteins, methods of detecting and isolating such proteins, and their use in agricultural systems.
    Type: Application
    Filed: February 4, 2016
    Publication date: June 2, 2016
    Applicant: Monsanto Technology LLC
    Inventors: James A. Baum, Artem G. Evdokimov, Farhad Moshiri, Timothy J. Rydel, Eric J. Sturman, Moritz von Rechenberg, Halong Vu, Andrew M. Wollacott, Meiying Zheng
  • Proteins toxic to hemipteran insect species
    Patent number: 9322033
    Abstract: The present invention discloses Hemipteran insect inhibitory proteins, methods of using such proteins, nucleotide sequences encoding such proteins, methods of detecting and isolating such proteins, and their use in agricultural systems.
    Type: Grant
    Filed: April 5, 2013
    Date of Patent: April 26, 2016
    Assignee: Monsanto Technology LLC
    Inventors: James A. Baum, Artem G. Evdokimov, Farhad Moshiri, Timothy J. Rydel, Eric J. Sturman, Moritz von Rechenberg, Halong Vu, Andrew M. Wollacott, Meiying Zheng
  • Proteins Toxic or Inhibitory to Lepidopteran Insects
    Publication number: 20160108427
    Abstract: Nucleotide sequences are disclosed encoding novel, insecticidal TIC2160 and TIC3244 proteins, and variants thereof, and related proteins exhibiting Lepidopteran inhibitory activity, as well as fragments thereof. Particular embodiments provide compositions and transformed plants, plant parts, and seeds containing a polynucleotide construct encoding one or more of the toxin proteins within the TIC2160-related protein toxin class.
    Type: Application
    Filed: October 15, 2015
    Publication date: April 21, 2016
    Applicant: MONSANTO TECHNOLOGY LLC
    Inventors: James Arthur Baum, David Joseph Bowen, Catherine Alice Chay, Artem G. Evdokimov, Stanislaw Flasinski, Uma Rao Kesanapalli, Jeffrey R. Nageotte, James Kevin Roberts, Brian Edward Weiner
  • HERBICIDE TOLERANCE GENES AND METHODS OF USE THEREOF
    Publication number: 20160108422
    Abstract: Polypeptides and recombinant DNA molecules useful for conferring tolerance to AOPP herbicides, phenoxy acid herbicides, and pyridinyloxy acid herbicides are provided in the present invention, as well as herbicide tolerant transgenic plants, seeds, cells, and plant parts containing the recombinant DNA molecules, as well as methods of using the same.
    Type: Application
    Filed: September 30, 2015
    Publication date: April 21, 2016
    Inventors: Christine M. Ellis, Artem G. Evdokimov, Paul C.C. Feng, Xiaoran Fu, Clayton T. Larue, Jeffrey R. Nageotte, Andrew C. Read, Lei Shi, Andrew M. Wollacott
  • PROLYL HYDROXYLASE INHIBITORS AND METHODS OF USE
    Publication number: 20160009648
    Abstract: The present disclosure relates to HIF-1? prolyl hydroxylase inhibitors, compositions which comprise the HIF-1? prolyl hydroxylase inhibitors described herein and to methods for controlling, inter alia, Peripheral Vascular Disease (PVD), Coronary Artery Disease (CAD), heart failure, ischemia, and anemia.
    Type: Application
    Filed: September 15, 2015
    Publication date: January 14, 2016
    Inventors: Richard Masaru Kawamoto, Shengde Wu, Artem G. Evdokimov, Kenneth D. Greis, Angelique Sun Boyer, Namal C. Warshakoon
  • PROLYL HYDROXYLASE INHIBITORS AND METHODS OF USE
    Publication number: 20150119425
    Abstract: The present disclosure relates to HIF-1? prolyl hydroxylase inhibitors, compositions which comprise the HIF-1? prolyl hydroxylase inhibitors described herein and to methods for controlling, inter alia, Peripheral Vascular Disease (PVD), Coronary Artery Disease (CAD), heart failure, ischemia, and anemia.
    Type: Application
    Filed: December 12, 2014
    Publication date: April 30, 2015
    Inventors: Richard Masaru Kawamoto, Shengde Wu, Artem G. Evdokimov, Kenneth D. Greis, Angelique Sun Boyer, Namal C. Warshakoon
  • Prolyl hydroxylase inhibitors and methods of use
    Patent number: 8940773
    Abstract: The present disclosure relates to HIF-1? prolyl hydroxylase inhibitors, compositions which comprise the HIF-1? prolyl hydroxylase inhibitors described herein and to methods for controlling, inter alia, Peripheral Vascular Disease (PVD), Coronary Artery Disease (CAD), heart failure, ischemia, and anemia.
    Type: Grant
    Filed: October 24, 2013
    Date of Patent: January 27, 2015
    Assignee: Akebia Therapeutics, Inc.
    Inventors: Richard Masaru Kawamoto, Shengde Wu, Artem G. Evdokimov, Kenneth D. Greis, Angelique Sun Boyer, Namal C. Warshakoon
  • COMPOSITIONS AND METHODS FOR CUSTOM SITE-SPECIFIC DNA RECOMBINASES
    Publication number: 20140193915
    Abstract: The invention relates to biotechnology and provides novel compositions and methods for sequence-specific or sequence-directed transcription activator-like effector recombinases. The invention also provides novel plant transformation vectors and expression cassettes, which include novel combinations of chimeric recombinases with plant expression and transformation elements. Methods for gene-targeting, DNA sequence removal, and molecular breeding are also provided.
    Type: Application
    Filed: December 17, 2013
    Publication date: July 10, 2014
    Applicant: Monsanto Technology, LLC
    Inventors: Jonathan C. Lamb, Artem G. Evdokimov
  • Prolyl hydroxylase inhibitors and method of use
    Patent number: 8722895
    Abstract: The present disclosure relates to HIF-1? prolyl hydroxylase inhibitors, compositions which comprise the HIF-1? prolyl hydroxylase inhibitors described herein and to methods for controlling, inter alia, Peripheral Vascular Disease (PVD), Coronary Artery Disease (CAD), heart failure, ischemia, and anemia.
    Type: Grant
    Filed: April 9, 2013
    Date of Patent: May 13, 2014
    Assignee: Akebia Therapeutics, Inc.
    Inventors: Richard M. Kawamoto, Shengde Wu, Artem G. Evdokimov, Kenneth D. Greis, Angelique Sun Boyer, Namal C. Warshakoon
  • PROLYL HYDROXYLASE INHIBITORS AND METHODS OF USE
    Publication number: 20140057892
    Abstract: The present disclosure relates to HIF-1? prolyl hydroxylase inhibitors, compositions which comprise the HIF-1? prolyl hydroxylase inhibitors described herein and to methods for controlling, inter alia, Peripheral Vascular Disease (PVD), Coronary Artery Disease (CAD) heart failure, ischemia, and anemia.
    Type: Application
    Filed: November 4, 2013
    Publication date: February 27, 2014
    Applicant: Akebia Therapeutics, Inc.
    Inventors: Richard Masaru Kawamoto, Shengde Wu, Artem G. Evdokimov, Kenneth D. Greis, Angelique Sun Boyer, Namal C. Warshakoon
  • PROLYL HYDROXYLASE INHIBITORS AND METHODS OF USE
    Publication number: 20140045899
    Abstract: The present disclosure relates to HIF-1? prolyl hydroxylase inhibitors, compositions which comprise the HIF-1? prolyl hydroxylase inhibitors described herein and to methods for controlling, inter alia, Peripheral Vascular Disease (PVD), Coronary Artery Disease (CAD), heart failure, ischemia, and anemia.
    Type: Application
    Filed: October 24, 2013
    Publication date: February 13, 2014
    Applicant: Akebia Therapeutics, Inc.
    Inventors: Richard Masaru Kawamoto, Shengde Wu, Artem G. Evdokimov, Kenneth D. Greis, Angelique Sun Boyer, Namal C. Warshakoon
  • Prolyl hydroxylase inhibitors and methods of use
    Patent number: 8598210
    Abstract: The present disclosure relates to HIF-1? prolyl hydroxylase inhibitors, compositions which comprise the HIF-1? prolyl hydroxylase inhibitors described herein and to methods for controlling, inter alia, Peripheral Vascular Disease (PVD), Coronary Artery Disease (CAD), heart failure, ischemia, and anemia.
    Type: Grant
    Filed: November 20, 2012
    Date of Patent: December 3, 2013
    Assignee: Akebia Therapeutics, Inc.
    Inventors: Richard Masaru Kawamoto, Shengde Wu, Namal C. Warshakoon, Artem G. Evdokimov, Kenneth D. Greis, Angelique Sun Boyer
  • Proteins Toxic To Hemipteran Insect Species
    Publication number: 20130269060
    Abstract: The present invention discloses Hemipteran insect inhibitory proteins, methods of using such proteins, nucleotide sequences encoding such proteins, methods of detecting and isolating such proteins, and their use in agricultural systems.
    Type: Application
    Filed: April 5, 2013
    Publication date: October 10, 2013
    Applicant: MONSANTO TECHNOLOGY LLC
    Inventors: James A. Baum, Artem G. Evdokimov, Farhad Moshiri, Timothy J. Rydel, Eric J. Sturman, Moritz von Rechenberg, Halong Vu, Andrew M. Wollacott, Meiying Zheng